Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study

Sleep and Breathing

Volumn 20, Issue 2, 2016, Pages 627-634

  Xu, Huajun ^a,b   Guan, Jian ^a,b   Yi, Hongliang ^a,b   Zou, Jianyin ^b   Meng, Lili ^a   Tang, Xulan ^a   Zhu, Huaming ^a   Yu, Dongzhen ^a,b   Zhou, Huiqun ^a   Su, Kaiming ^a,b   Wang, Yue ^c   Wang, Jian ^d   Yin, Shankai ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Dyslipidemia; Lipids; Obesity; Obstructive sleep apnea

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; EPWORTH SLEEPINESS SCALE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SLEEP DISORDERED BREATHING; SMOKING; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; BLOOD; CHINA; HYPERCHOLESTEROLEMIA; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; STATISTICS;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHINA; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC;

EID: 84944707605     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-015-1262-3     Document Type: Article

References (31)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
2. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW et al (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177:1006–1014
3. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93
4. Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484
5. Baguet JP, Barone-Rochette G, Tamisier R, Levy P, Pepin JL (2012) Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 9:679–688
6. Rader DJ, Hovingh GK (2014) HDL and cardiovascular disease. Lancet 384:618–625
7. Ridker PM (2014) LDL cholesterol: controversies and future therapeutic directions. Lancet 384:607–617
8. Nordestgaard BG, Varbo A (2014) Triglycerides and cardiovascular disease. Lancet 384:626–635
9. Toyama Y, Chin K, Chihara Y, Takegami M, Takahashi K et al (2013) Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. Chest 143:720–728
10. Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P et al (2013) Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143:1584–1589
11. Togeiro SM, Carneiro G, Ribeiro Filho FF, Zanella MT, Santos-Silva R et al (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851
12. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12–17
13. Nadeem R, Singh M, Nida M, Waheed I, Khan A et al (2014) Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10:475–489
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752
16. Wang C, Hou X, Bao Y, Pan J, Zuo Y et al (2010) The metabolic syndrome increased risk of cardiovascular events in Chinese—a community based study. Int J Cardiol 139:159–165
17. Peng LL, Li JR, Sun JJ, Li WY, Sun YM et al (2011) Reliability and validity of the simplified Chinese version of Epworth sleepiness scale. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46:44–49
18. Iber C, Ancoli-Israel S, Chesson AL, SF Q (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications for the American Academy of Sleep Medicine. 1st ed. American Academy of Sleep Medicine, Westchester, IL
19. Togeiro SMCG, Ribeiro Filho FF, Zanella MT, Santos-Silva R, Taddei JA, Bittencourt LR, Tufik S (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity (Silver Spring) 21:847–851
20. Bhattacharjee R, Hakim F, Gozal D (2012) Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and children. Clin Lipidol 7:203–214
21. Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E et al (2006) Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129:233–237
22. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741
23. Tan KC, Chow WS, Lam JC, Lam B, Wong WK et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382
24. Michailidis V, Steiropoulos P, Nena E, Papanas N, Maltezos E et al (2011) Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea. Open Cardiovasc Med J 5:231–238
25. McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195
26. Keenan BT, Maislin G, Sunwoo BY, Arnardottir ES, Jackson N et al (2014) Obstructive sleep apnoea treatment and fasting lipids: a comparative effectiveness study. Eur Respir J 44:405–414
27. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N et al (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392
28. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22
29. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM (1991) The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14:I1–16
30. Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A (2010) PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55:2833–2842
31. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681